Clinicopathological Characteristics and Prognosis of Remnant Gastric Cancer

被引:21
作者
Lee, Sang Bong [1 ]
Kim, Jae Hun [1 ]
Kim, Dae Hwan [1 ]
Jeon, Tae Yong [1 ]
Kim, Dong Heon [1 ]
Kim, Gwang Ha [2 ]
Park, Do Youn [3 ]
机构
[1] Pusan Natl Univ, Postgrad Sch Med, Dept Surg, Busan, South Korea
[2] Pusan Natl Univ, Postgrad Sch Med, Internal Med, Busan, South Korea
[3] Pusan Natl Univ, Postgrad Sch Med, Pathol, Busan, South Korea
关键词
Gastric remnant cancer; Prognosis; Survival;
D O I
10.5230/jgc.2010.10.4.219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The long-term survival rate of gastric cancer patients after surgery has recently increased as a result of making an early diagnosis of gastric cancer. Therefore, the incidence of remnant gastric cancer is increasing. This study was performed to evaluate the clinicopathological characteristics and prognosis of patients with remnant gastric cancer. Materials and Methods: From January 2005 to December 2009, twenty-nine patients with remnant gastric cancer and who underwent surgery at Pusan National University Hospital were enrolled in this study. We retrospectively reviewed and analyzed their medical records. We also divided them into two groups: the remnant gastric cancer (RGC)-B group (first operation for benign disease) and the RGC-M group (first operation for malignant disease). Results: The RGC-B group included ten patients and the RGC-M group included nineteen patients. The mean interval between the first and second operations was 17 years. The curative resection rate was 93.1% (27/29). The postoperative complication rate was 20.7% (6/29) and there was no perioperative mortality. Ten (37%) of twenty-seven patients experienced recurrence after curative resection and eight patients (27.6%) expired due to aggravation of remnant stomach cancer. An advanced TNM stage and non-curative resection were the negative prognostic factors for survival for patients with remnant stomach cancer (P=0.0453 and P<0.001). The RGC-M group showed a shorter interval (P<0.001) and the RGC-B group had more advanced TNM stage (P=0.003). Conclusions: Long-term follow-up should be considered not only for patients who undergo an operation for malignant disease, but also for the patients who underwent an operation for benign disease. When remnant gastric cancer is diagnosed, curative resection is essential to improve the survival.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 16 条
[1]   Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy [J].
Ahn, Hye Seong ;
Kim, Jong Won ;
Yoo, Moon-Won ;
Park, Do Joong ;
Lee, Hyuk-Joon ;
Lee, Kuhn Uk ;
Yang, Han-Kwang .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (06) :1632-1639
[2]   Clinical significance of tumor location in remnant gastric cancers developed after partial gastrectomy for primary gastric cancer [J].
An, Ji Yeong ;
Youn, Ho Geun ;
Ha, Tae Kyung ;
Choi, Min Gew ;
Kim, Kyoung-Mee ;
Noh, Jae Hyung ;
Sohn, Tae Sung ;
Kim, Sung .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (04) :689-694
[3]   Gastric remnant cancer: an old problem with novel concerns [J].
Firat, Ozgur ;
Guler, Adem ;
Sozbilen, Murat ;
Ersin, Sinan ;
Kaplan, Hasan .
LANGENBECKS ARCHIVES OF SURGERY, 2009, 394 (01) :93-97
[4]   GASTRIC REMNANT CANCER AS A METACHRONOUS MULTIPLE LESION [J].
FURUKAWA, H ;
IWANAGA, T ;
HIRATSUKA, M ;
IMAOKA, S ;
ISHIKAWA, O ;
KABUTO, T ;
SASAKI, Y ;
KAMEYAMA, M .
BRITISH JOURNAL OF SURGERY, 1993, 80 (01) :54-56
[5]   Progression and Prognosis of Gastric Stump Cancer [J].
Hu, Xiang ;
Tian, Da-Yu ;
Cao, Liang ;
Yi, Yu .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (06) :472-476
[6]  
Kaminishi M, 1996, CANCER, V77, P1646, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1646::AID-CNCR10>3.0.CO
[7]  
2-Y
[8]   Early gastric stump cancer following distal gastrectomy [J].
Kaneko, K ;
Kondo, H ;
Saito, D ;
Shirao, K ;
Yamaguchi, H ;
Yokota, T ;
Yamao, G ;
Sano, T ;
Sasako, M ;
Yoshida, S .
GUT, 1998, 43 (03) :342-344
[9]  
Kodera Y, 1996, J AM COLL SURGEONS, V182, P1
[10]   Gastric cancer in Korea [J].
Lee H.-J. ;
Yang H.-K. ;
Ahn Y.-O. .
Gastric Cancer, 2002, 5 (3) :177-182